Alpha Profiles · Company Profile

BIOCRYST PHARMACEUTICALS INC

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/biocryst-pharmaceuticals-inc

Entity: Public listing published
Primary listing: NASDAQ: BCRX
Verification: Partially verified
Last reviewed: 2026-09-14T14:36:11.6197+00:00

Overview

Alpha's canonical identity and public leadership record for BIOCRYST PHARMACEUTICALS INC.

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

8 public records

Alane P. Barnes

Chief Legal Officer and Corporate Secretary

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001628280-26-026822Apr 23, 2026

Anthony J. Doyle

Chief Financial Officer (resigned effective April 9, 2025)

State: confirmed
Effective: From Apr 23, 2026
Confidence: 94%
Evidence: BCRX DEF 14A executive officersApr 23, 2026

Babar Ghias

Chief Financial Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001628280-26-026822Apr 23, 2026

Charles K. Gayer

President and Chief Executive Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001628280-26-026822Apr 23, 2026

Helen M. Thackray

Chief Research and Development Officer (resigned effective September 1, 2025)

State: confirmed
Effective: From Apr 23, 2026
Confidence: 94%
Evidence: BCRX DEF 14A executive officersApr 23, 2026

Jon P. Stonehouse

Chief Executive Officer (retired effective December 31, 2025)

State: confirmed
Effective: From Apr 23, 2026
Confidence: 94%
Evidence: BCRX DEF 14A executive officersApr 23, 2026

Ronald S. Dullinger

Chief Commercial Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001628280-26-026822Apr 23, 2026

Sandeep M. Menon

Chief Research and Development Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001628280-26-026822Apr 23, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 14, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.